Aldosterone linked to increased risk of chronic kidney disease progression and end-stage kidney disease

Synthetic ‘forever chemical’ linked to liver cancer
8 August 2022
Researchers identify new target for therapies to treat preterm labor
9 August 2022

Aldosterone linked to increased risk of chronic kidney disease progression and end-stage kidney disease

A steroid hormone called aldosterone is linked to an increased risk of kidney failure in patients with chronic kidney disease (CKD), according to a study published in the European Heart Journal today. The risk of CKD worsening and developing into end-stage kidney disease was independent of whether or not patients had diabetes.

Comments are closed.